The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Turkish Version of Digital Eye Strain Questionnaire (DESQ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06054542
Recruitment Status : Not yet recruiting
First Posted : September 26, 2023
Last Update Posted : September 26, 2023
Sponsor:
Information provided by (Responsible Party):
Ayse Unal, Alanya Alaaddin Keykubat University

Brief Summary:
The aims of this study were to perform cultural adaptation of the DESQ and provide information regarding the factor structure, reliability and validity of the instrument in Turkish speaking adults.

Condition or disease Intervention/treatment
Cultural Adaptation Reliability Validity Adults Eye Strain Other: Cultural adaptation, reliability and validity

Layout table for study information
Study Type : Observational
Estimated Enrollment : 130 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Validity and Reliability of the Turkish Version of Digital Eye Strain Questionnaire (DESQ)
Estimated Study Start Date : October 2023
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : June 2024

Intervention Details:
  • Other: Cultural adaptation, reliability and validity
    Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the DESQ


Primary Outcome Measures :
  1. DESQ [ Time Frame: 10 minutes ]
    Digital Eye Strain Questionnaire (DESQ) is a thirteen-item self-report scale in a yes-no format designed to offer a measure of complaints related to digital eye strain syndrome (DES)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy adults who spend two or more continuous hours a day on their digital devices (computer, tablet, smartphone) or use more than one device
Criteria

Inclusion Criteria:

  • Between the ages of 18-65 years
  • People who spend two or more continuous hours a day on their digital devices (computer, tablet, smartphone) or use more than one device

Exclusion Criteria:

  • History of ophthalmic surgery or active ocular disease
  • Participants who did not understand the instructions or did not sign a consent form were excluded

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06054542


Contacts
Layout table for location contacts
Contact: Ayşe Ünal, Assoc. Prof. +90(242)510 6060 ext 4329 pt.aunal@gmail.com
Contact: Ayça Aracı, Asst. Prof. +90(242)510 6060 ext 4338 ayca.araci@alanya.edu.tr

Sponsors and Collaborators
Alanya Alaaddin Keykubat University
Layout table for additonal information
Responsible Party: Ayse Unal, Assoc. Prof., Alanya Alaaddin Keykubat University
ClinicalTrials.gov Identifier: NCT06054542    
Other Study ID Numbers: 20.09.2023/DESQ
First Posted: September 26, 2023    Key Record Dates
Last Update Posted: September 26, 2023
Last Verified: September 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Asthenopia
Sprains and Strains
Wounds and Injuries
Eye Diseases